Literature DB >> 6987662

Thrombin increases expression of fibronectin antigen on the platelet surface.

M H Ginsberg, R G Painter, J Forsyth, C Birdwell, E F Plow.   

Abstract

Fibronectins (fn) are adhesive glycoproteins which bind to collagen and to fibrin and appear to be important in cellular adhesion to other cells or surfaces. Fn-related antigen is present in human platelets, suggesting a possible role for fn in the adhesive properties of platelets. We have studied the localization of fn in resting and thrombin-stimulated platelets by immunofluorescence and quantitative binding of radiolabeled antibody. In resting fixed platelets, variable light surface staining for fn was observed. When these cells were made permeable to antibody with detergent, staining for fn was markedly enhanced and was present in a punctate distribution, suggesting intracellular localization. Stimulation with thrombin, which is associated with increased platelet adhesiveness, resulted in increased staining for fn antigen on intact platelets. These stimulated cells did not leak 51Cr nor did they stain for F-actin, thus documenting that the increased fn staining was not due to loss of plasma membrane integrity. The thrombin-induced increase in accessible platelet fn antigen was confirmed by quantitative antibody binding studies in which thrombin-stimulated platelets specifically bound 15 times as much radiolabeled F(ab')2 anti-fn as did resting cells. Thus, thrombin stimulation results in increased expression of fn antigen on the platelet surface. Here it may participate in interactions with fibrin, connective tissue, or other cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987662      PMCID: PMC348421          DOI: 10.1073/pnas.77.2.1049

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts.

Authors:  K M Yamada; S S Yamada; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

2.  Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein.

Authors:  I U Ali; V Mautner; R Lanza; R O Hynes
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Alteration of cell-surface proteins by viral transformation and by proteolysis.

Authors:  R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

6.  Comparison of the coagulant activities of platelets and phospholipids.

Authors:  P N Walsh; M S Lipscomb
Journal:  Br J Haematol       Date:  1976-05       Impact factor: 6.998

7.  Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.

Authors:  D F Mosher
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

8.  Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranes.

Authors:  D R Phillips; P P Agin
Journal:  Biochim Biophys Acta       Date:  1974-06-13

9.  Fibroblast surface antigen produced but not retained by virus-transformed human cells.

Authors:  A Vaheri; E Ruoslahti
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Use of the avidin-biotin complex for the localization of actin and myosin with fluorescence microscopy.

Authors:  M H Heggeness; J F Ash
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

View more
  23 in total

1.  Plasma membrane GPIIb/IIIa. Evidence for a cycling receptor pool.

Authors:  J D Wencel-Drake
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

2.  Use of biocarrier beads and flow cytometry for single-cell studies of fibronectin gene regulation in dibutyryl cyclic AMP reverse transformed CHO-K1 cells.

Authors:  J M Sterner; J F Leary
Journal:  Cell Biophys       Date:  1989-12

3.  Reactivity of mouse antibodies against bromelain-treated mouse erythrocytes with thrombin-treated mouse platelets.

Authors:  S Kawaguchi
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

4.  Fibronectin in neoplastic peritoneal effusions in dogs.

Authors:  B F Feldman; E Brummerstedt; L S Larsen; S Larsen
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

5.  Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses.

Authors:  J D Wencel-Drake; E F Plow; T J Kunicki; V L Woods; D M Keller; M H Ginsberg
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

6.  Platelet stimulation by antifibronectin antibodies requires the Fc region of antibody.

Authors:  D Holderbaum; L A Culp; H B Bensusan; H Gershman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets.

Authors:  M H Ginsberg; J Forsyth; A Lightsey; J Chediak; E F Plow
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Platelet fibronectin release induced by Walker 256 rat carcinoma tumor cells.

Authors:  W A Turner; D C Szlag; J D Taylor
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

9.  A fibronectin-binding glycoprotein from human platelet membranes.

Authors:  M S Hansen; I Clemmensen
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

Review 10.  Fibronectin maintains the balance between hemostasis and thrombosis.

Authors:  Yiming Wang; Heyu Ni
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.